1. business and industrial

Anaplastic Oligoastrocytoma Market : Global Industry Analysis
and Forecast 2016 - 2024
Persistence Market Research
Anaplastic Oligoastrocytoma Market : Global
Industry Analysis and Forecast 2016 - 2024
Persistence Market Research
1
Anaplastic Oligoastrocytoma Market : Global Industry Analysis
and Forecast 2016 - 2024
Persistence Market Research Released New Market Report on “Anaplastic Oligoastrocytoma
Market : Global Industry Analysis and Forecast 2016 - 2024”.
Oligoastrocytomas is a part of a group of brain tumor called “gliomas”. Glioma tumor is
originated in the brain or spine. Oligoastrocytomas contains both astrocytoma cells and
oligodendroglioma. About 2.3% of the brain tumors reported are diagnosed as
oligoastrocytomas. Oligoastrocytomas is divided into two parts, low grade and anaplastic.
According to the WHO grading system, anaplastic oligoastrocytomas are usually identify as
grade 1 and grade 2 but sometimes they appear to be grade 4. Anaplastic oligoastrocytomas
can be characterized by high cellularity, conspicuous cytologic atypism, microvascular
proliferation, mitotic activity and necrosis. Patients suffering from this condition show symptoms
like headache, seizure and speech or motor changes. According to the American Brain Cancer
Association, clinical trials for the treatment of this tumor are in process to minimize the
recurrence rate of anaplastic oligoastocytoma caused after the surgical removal of tumor or
chemotherapy and radiation therapy session.
Interested in report: Please follow the below links to meet your requirements; Request
for the Report Sample: http://www.persistencemarketresearch.com/samples/10502
Anaplastic oligoastrocytomas market is offers potential opportunities to cancer care industry.
Factors contributing the growth of anaplastic oligoastrocytomas market are rising geriatric
population, increasing incidence of anaplastic oligoastrocytomas and increasing pace of clinical
trials for novel drug development. Moreover factors such as advancement in technology and
innovations in diangositc techniques is expected to drive the growth of anaplastic
oligoastrocytoma market over the forecast period. However, lack of specific treatment and
critical diagnosis of anaplastic oligoastrocytoma is the major challenge for anaplastic
oligoastrocytomas market.
Persistence Market Research
2
Anaplastic Oligoastrocytoma Market : Global Industry Analysis
and Forecast 2016 - 2024
Basically the treatment of anaplastic oligoastrocytoma depends on the size of the tumor. The
treatment is processed by surgery to remove the tumor. In order to eliminate the cancerous
cells, the combinational therapies such as chemotherapy or radiation therapy are used as
effective treatment for anaplastic oligoastrocytoma.
Request TOC (table of content), Figures and Tables of the Report:
http://www.persistencemarketresearch.com/toc/10502
Anaplastic oligoastrocytoma market is segmented on basis of treatment Type, end user
and region:
By Treatment Type
•
Chemotherapy
•
Radiation
By End Use
•
Hospitals
•
Cancer Centers
•
Surgical Centers
Oligoastrocytomas is most common in adults and generally occurs at the age of 35–50.
Generally these type of tumors are found in both the genders. Children of age 0-14 are often
diagnosed with oligoastrocytomas and these tumors comprises of only three percent of primary
brain tumors. Factors such as increasing demand for treatment therapies for anaplastic
oligoastrocytoma, increasing prevalence of anaplastic oligoastrocytoma in emerging economies
are expected provide traction to the growth of anaplastic oligoastrocytoma over the forecast
period (2016-2026)
Persistence Market Research
3
Anaplastic Oligoastrocytoma Market : Global Industry Analysis
and Forecast 2016 - 2024
On the basis of region presence, anaplastic oligoastrocytoma market is segmented into five key
regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The
North America and Europe market are at maturity level for clinical research of treatment for
anaplastic oligoastrocytomas. Markets of Asia-Pacific region have also shown keen interest in
clinical trials of this tumor and are showing growth at faster pace, due to increasing incidence of
anaplastic oligoastrocytoma.
Following are the companies and institutions which are involved in clinical trials of treatment for
anaplastic oligoastocytomas are Tocagen, Inc., Shandong Lanjin Pharmaceuticals Co. Ltd,
Keryx Biopharmaceuticals, Inc., Biogen Idec, Inc., Insys Therapeutics, Inc, Rush University
Medical Center and University of California, San Diego.
The report covers exhaustive analysis on:
•
Anaplastic Oligoastrocytoma Market Segments
•
Anaplastic Oligoastrocytoma Market Dynamics
•
Historical Actual Market Size, 2013 - 2015
•
Anaplastic Oligoastrocytoma Market Size & Forecast 2016 to 2022
•
Anaplastic Oligoastrocytoma Current Trends/Issues/Challenges
•
Competition & Companies involved
•
Anaplastic Oligoastrocytoma Drivers and Restraints
Regional analysis includes
Persistence Market Research
4
Anaplastic Oligoastrocytoma Market : Global Industry Analysis
and Forecast 2016 - 2024
•
North America
•
Latin America
•
Europe
•
Asia Pacific
•
Middle East & Africa
Report Highlights:
•
Shifting Industry dynamics
•
In-depth market segmentation
•
Historical, current and projected industry size Recent industry trends
•
Key Competition landscape
•
Strategies of key players and product offerings
•
Potential and niche segments/regions exhibiting promising growth
•
A neutral perspective towards market performance
About Us:
Persistence Market Research (PMR) is a full-service market intelligence firm specializing in
syndicated research, custom research, and consulting services. PMR boasts market research
expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and
Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping
and Transportation industries. The company draws from its multi-disciplinary capabilities and
high-pedigree team of analysts to share data that precisely corresponds to clients’ business
needs.
Persistence Market Research
5
Anaplastic Oligoastrocytoma Market : Global Industry Analysis
and Forecast 2016 - 2024
PMR stands committed to bringing more accuracy and speed to clients’ business decisions.
From ready-to-purchase market research reports to customized research solutions, PMR’s
engagement models are highly flexible without compromising on its deep-seated research
values.
Contact Us:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com
Persistence Market Research
6